Skip to content
OpenCapital
Get started

Viridian Therapeutics, Inc. VRDN Quick ratio

Quick ratio at other companies

Amgen logo
AmgenAMGN
1×+0.1×
Immunovant, Inc. logo
Immunovant, Inc.IMVT
9.1×-2.1×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
2.5×+0.5×
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
7.1×+0.3×
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
10.2×+7.0×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
5.1×-0.7×

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%—
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Calculated from Viridian Therapeutics, Inc.’s reported figures.

quick assets/total current liabilities=15.1×

Based on the most recent quarter.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s quick ratio?
Viridian Therapeutics, Inc. (VRDN) reported quick ratio of 15.1× in Q1 2026.
How has Viridian Therapeutics, Inc.'s quick ratio changed year-over-year?
Viridian Therapeutics, Inc.'s quick ratio decreased by 22.3% year-over-year, from 19.5× to 15.1×.
What is the long-term trend for Viridian Therapeutics, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s quick ratio has grown at a 0.8% compound annual growth rate (CAGR), from 12.1× to 12.6×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.